119 related articles for article (PubMed ID: 6503348)
1. Developmental and application of insulin infusion profiles for therapy of type-I diabetics with portable insulin infusion systems.
Schulz G; Strack T; Beyer J; Krause U; Cordes U; Weber T; Nagel J; Beutelspacher F
Life Support Syst; 1984; 2(3):189-200. PubMed ID: 6503348
[TBL] [Abstract][Full Text] [Related]
2. Effect of a local heating device on insulin and glucose pharmacokinetic profiles in an open-label, randomized, two-period, one-way crossover study in patients with type 1 diabetes using continuous subcutaneous insulin infusion.
Raz I; Weiss R; Yegorchikov Y; Bitton G; Nagar R; Pesach B
Clin Ther; 2009 May; 31(5):980-7. PubMed ID: 19539098
[TBL] [Abstract][Full Text] [Related]
3. Pre- and postprandial hyperinsulinemia during insulin pump treatment; role of the subcutaneous bolus and basal infusion.
Olsson PO; Jorfeldt L; Arnqvist H; Gerhardsson P
Diabetes Res; 1991 Feb; 16(2):55-61. PubMed ID: 1817806
[TBL] [Abstract][Full Text] [Related]
4. Development of individual insulin infusion profiles for open loop infusion systems.
Strack T; Krause U; Schulz G; Beyer J; Beutelspacher F; Nagel J
Horm Metab Res; 1984 Apr; 16(4):163-7. PubMed ID: 6547110
[TBL] [Abstract][Full Text] [Related]
5. [Effect of acarbose on postprandial increase in blood glucose. Additive acute effect of once daily administration in insulin treated diabetes].
Ledermann H; Höxter G
Fortschr Med; 1994 Nov; 112(32):467-70. PubMed ID: 7821886
[TBL] [Abstract][Full Text] [Related]
6. Insulin kinetics in type I diabetic patients treated by continuous intraperitoneal insulin infusion: influence of anti-insulin antibodies.
Lassmann-Vague V; Belicar P; Alessis C; Raccah D; Vialettes B; Vague P
Diabet Med; 1996 Dec; 13(12):1051-5. PubMed ID: 8973887
[TBL] [Abstract][Full Text] [Related]
7. Continuous subcutaneous insulin infusion in the treatment of juvenile-onset diabetes.
Buysschaert M; Lejeune M; Lambert AE
Diabete Metab; 1981 Sep; 7(3):189-93. PubMed ID: 7319116
[TBL] [Abstract][Full Text] [Related]
8. Preprandial and postprandial variations of insulin sensitivity in different times of the day assessed by the artificial pancreas in type I diabetics.
Trovati M; Bruno A; Lorenzati R; Caselle MT; Pagani A; Gorzegno G; Pagano G
Chronobiologia; 1981; 8(4):333-40. PubMed ID: 7035094
[TBL] [Abstract][Full Text] [Related]
9. The dual-wave bolus feature in continuous subcutaneous insulin infusion pumps controls prolonged post-prandial hyperglycaemia better than standard bolus in Type 1 diabetes.
Lee SW; Cao M; Sajid S; Hayes M; Choi L; Rother C; de León R
Diabetes Nutr Metab; 2004 Aug; 17(4):211-6. PubMed ID: 15575341
[TBL] [Abstract][Full Text] [Related]
10. A portable, pre-programmable insulin infusion system in diabetes mellitus.
Kølendorf K; Bojsen J
Horm Metab Res Suppl; 1979; (8):191-3. PubMed ID: 395078
[TBL] [Abstract][Full Text] [Related]
11. [Blood-sugar-controlled insulin infusion systems for rapid adjustment of insulin-dependent diabetics (author's transl)].
Beyer J; Becker G; Schulz G; Gaberle E; Wolf E; Hassinger W; Cordes U
Dtsch Med Wochenschr; 1981 Dec; 106(49):1644-9. PubMed ID: 7030687
[TBL] [Abstract][Full Text] [Related]
12. A 2-way cross-over, open-labeled trial to compare efficacy and safety of insulin Aspart and Novolin R delivered with CSII in 21 Chinese diabetic patients.
Bi YF; Zhao LB; Li XY; Wang WQ; Sun SY; Chen YH; Hong J; Su TW; Liu JM; Ning G
Chin Med J (Engl); 2007 Oct; 120(19):1700-3. PubMed ID: 17935674
[TBL] [Abstract][Full Text] [Related]
13. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
Rosak C; Haupt E; Walter T; Werner J
Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
[TBL] [Abstract][Full Text] [Related]
14. Postprandial insulin profiles with implantable pump therapy may explain decreased frequency of severe hypoglycemia, compared with intensive subcutaneous regimens, in insulin-dependent diabetes mellitus patients.
Nathan DM; Dunn FL; Bruch J; McKitrick C; Larkin M; Haggan C; Lavin-Tompkins J; Norman D; Rogers D; Simon D
Am J Med; 1996 Apr; 100(4):412-7. PubMed ID: 8610727
[TBL] [Abstract][Full Text] [Related]
15. Studies on the clinical importance of the constants used in the algorithm of an artificial B-cell (Biostator).
Ratzmann KP; Jutzi E; Albrecht G
Z Exp Chir Transplant Kunstliche Organe; 1983; 16(5):270-6. PubMed ID: 6359740
[TBL] [Abstract][Full Text] [Related]
16. Attempts at perfect normalization of glucose tolerance test of severe diabetics by artificial beta cell.
Kerner W; Thum C; Tamás G; Beischer W; Clemens AH; Pfeiffer EF
Horm Metab Res; 1976 Jul; 8(4):256-61. PubMed ID: 783030
[TBL] [Abstract][Full Text] [Related]
17. [Treatment of diabetics using portable insulin pumps].
Vavrinec J; Kopecký A; Zizkovský V; Lebl J; Sturmová M
Cesk Pediatr; 1985 Dec; 40(12):701-4. PubMed ID: 4085018
[No Abstract] [Full Text] [Related]
18. Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas.
Weinzimer SA; Steil GM; Swan KL; Dziura J; Kurtz N; Tamborlane WV
Diabetes Care; 2008 May; 31(5):934-9. PubMed ID: 18252903
[TBL] [Abstract][Full Text] [Related]
19. Glucose profiles in a type 1 diabetic patient successively treated with CSII using regular insulin, lispro and an implantable insulin pump.
Catargi B; Breilh D; Roger P; Tabarin A
Diabetes Metab; 2000 May; 26(3):210-4. PubMed ID: 10880895
[TBL] [Abstract][Full Text] [Related]
20. [Recommendations for insulin treatment with a portable insulin pump].
Gutniak M; Johansson BL; Lager I; Lins PE; Nilsson A; Reichard P; Ostman J
Lakartidningen; 1984 Nov; 81(48):4507-10. PubMed ID: 6521559
[No Abstract] [Full Text] [Related]
[Next] [New Search]
